Chlorotetracycline

Chlorotetracycline (CAS No.: 57-62-5) is a tetracycline class small molecule antibiotic of microbial origin, commonly classified in life sciences research as a broad spectrum antibacterial tool compound and mechanistic probe for translation inhibition, with additional use in microbiome and methanogen related studies where selective pressure on susceptible prokaryotes is required. Its primary mechanism is binding to the 30S ribosomal subunit to disrupt aminoacyl tRNA accommodation at the ribosomal acceptor site, thereby suppressing bacterial protein synthesis and producing predominantly bacteriostatic effects with context dependent bactericidal outcomes at higher exposure conditions, and published research on tetracycline class members further supports downstream perturbation of core bacterial pathways linked to translational control, stress adaptation, and growth associated metabolic flux. Across susceptible laboratory strains, reported antibacterial potency is generally observed from sub micromolar to low micromolar levels, while less sensitive organisms may require higher micromolar concentrations, and methanogen focused inhibition studies are typically interpreted within micromolar to tens of micromolar experimental windows depending on strain background and culture conditions. In biomedical discovery workflows, this compound is routinely applied in in vitro microbial susceptibility assays, ribosome focused mechanism studies, resistance evolution experiments, and host microbe interaction models, and it may also be incorporated into exploratory animal or ecological model designs to evaluate antimicrobial response dynamics under controlled nonclinical conditions; in all cases, the concentrations or doses used in experiments typically depend on specific experimental designs and research objectives.